Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1024 Events

🤖 AI Analyzed

Recent

📄 Page 69 of 86

Eventbrite, Inc.

8-K March 2, 2026

Key Highlights

Eventbrite shareholders overwhelmingly approved the acquisition by Bending Spoon...
Shareholders will receive $15.00 in cash for each share, valuing the entire tran...
The acquisition promises enhanced mobile experience, AI integration, and greater...

Read Analysis

🤖 AI Generated

TON Strategy Co

8-K March 2, 2026

Key Highlights

TON Strategy Co. (TONX) faces a significant leadership crisis in its Global Digi...
Rory J. Cutaia, the division's CEO, was terminated and subsequently resigned fro...
Mr. Cutaia accused the Board of "corporate waste" and "self-dealing," raising se...

Read Analysis

🤖 AI Generated

Lifeward Ltd.

8-K March 2, 2026

Key Highlights

Lifeward Ltd. successfully avoided delisting from Nasdaq by executing a 1-for-12...
Maintaining a Nasdaq listing provides credibility, visibility, and access to a b...
The higher share price post-split may attract institutional investors who have m...

Read Analysis

🤖 AI Generated

Shake Shack Inc.

8-K March 2, 2026

Key Highlights

Shake Shack's overall sales for fiscal year 2025 grew by a healthy 15.2% to $1.4...
The correction does not impact Shake Shack's overall reported total sales, net i...
The company's growth is more significantly driven by existing Shacks and other f...

Read Analysis

🤖 AI Generated

Intellia Therapeutics, Inc.

8-K March 2, 2026

Key Highlights

FDA lifted clinical hold on MAGNITUDE trial for nexiguran ziclumeran (nex-z), In...
Expanded 'at-the-market' (ATM) stock offering program by $400 million, increasin...
Removes a major regulatory obstacle, speeding up development for a potentially l...

Read Analysis

🤖 AI Generated

Iterum Therapeutics plc

8-K March 2, 2026

Key Highlights

Iterum Therapeutics (ITRM) faces imminent Nasdaq delisting due to unmet listing ...
The company is in severe financial distress, exploring options like winding down...
Shareholders are explicitly warned they are 'very unlikely to receive any meanin...

Read Analysis

🤖 AI Generated

Eton Pharmaceuticals, Inc.

8-K March 2, 2026

Key Highlights

Immediate revenue and profit growth from an established, FDA-approved product.
Strategic expansion into specialized pharmaceutical markets with an Orphan Drug ...
Efficient capital deployment, using existing cash for an immediately accretive a...

Read Analysis

🤖 AI Generated

Tilray Brands, Inc.

8-K March 2, 2026

Key Highlights

Tilray Brands acquired key operational assets from BrewDog Group, significantly ...
The acquisition, valued at approximately £33 million ($44.1 million USD), was fi...
Utilizing a 'pre-packaged administration' process, Tilray acquired valuable asse...

Read Analysis

🤖 AI Generated

TANCHENG GROUP CO., LTD.

8-K March 2, 2026

Key Highlights

TANCHENG GROUP CO., LTD. replaced its independent auditor, Onestop Assurance PAC...
The former auditor, Onestop Assurance, issued 'Substantial Doubt About the Compa...
Material Weaknesses in Internal Control Over Financial Reporting were identified...

Read Analysis

🤖 AI Generated

IAC Inc.

8-K March 2, 2026

Key Highlights

IAC Inc. is selling its entire stake in Care.com for $320 million in cash.
This divestiture is a key part of IAC's strategy to optimize its portfolio and f...
The $320 million cash proceeds provide IAC with significant financial flexibilit...

Read Analysis

🤖 AI Generated

HCW Biologics Inc.

8-K March 2, 2026

Key Highlights

HCW Biologics successfully regained compliance with Nasdaq listing requirements.
The immediate threat of delisting has been removed, ensuring continued stock liq...
This positive development boosts investor confidence and maintains the company's...

Read Analysis

🤖 AI Generated

Blend Labs, Inc.

8-K March 2, 2026

Key Highlights

Strategic pivot to focus on high-margin core software business, shedding non-cor...
Divestiture of Title365 generated $80 million in net cash, providing capital for...
Projected $50 million in annual cost savings, targeting adjusted EBITDA profitab...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage